<DOC>
	<DOCNO>NCT00763802</DOCNO>
	<brief_summary>This project aim validate predictive model diabetic retinopathy progression clinically significant macular edema ( CSME ) need photocoagulation and/or vision loss . The Coimbra Predictive Model ( CPM ) , base retinal thickness , microaneurysms number , HbA1C LDL level , establish set 52 diabetic patient , test population 400 patients/eyes enrol study . These patient perform 2 visit 6-month interval ( V0 V6 ) classify patient one 3 previously establish phenotype . Two year ( V24 ) patient reexamine . The occurrence end-points , achieve patient , expect validate predictive model .</brief_summary>
	<brief_title>Validation Predictive Model Estimate Risk Conversion Clinically Significant Macular Edema and/or Vision Loss Mild Nonproliferative Diabetic Retinopathy Diabetes Type 2</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diabetes type 2 accord 1985 WHO criteria . Age 35 75 year . Mild nonprolipherative retinopathy ( base ETDRS criterion ) Best Corrected Visual acuity &gt; 20 /25 Refraction spherical equivalent le 5 Dp . Inform consent Cataract eye disease may interfere fundus examination Glaucoma Vitreous syneresis posterior vitreous detachment Other retinal vascular disease Recent intraocular surgery Previous laser therapy Dilatation pupil &lt; 5 mm</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>